Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP)
Alessandro Di Minno, Achille Aveta, Monica Gelzo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6102-6102
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10846-10846
Open Access | Times Cited: 53
Biomarkers for Prostate Cancer: From Diagnosis to Treatment
Jiayan Chen, Peiyan Wang, Mingzhu Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3350-3350
Open Access | Times Cited: 23
Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance
Yang Zhao, Mengmeng Zhou, Yongfang Shang, et al.
Diabetes and Vascular Disease Research (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Echinacoside: A promising active natural products and pharmacological agents
Wang Wang, Shujun Jiang, Yang Zhao, et al.
Pharmacological Research (2023) Vol. 197, pp. 106951-106951
Open Access | Times Cited: 19
A Novel Low-Cost Uroflowmetry for Patient Telemonitoring
Savio Domenico Pandolfo, Federica Crauso, Achille Aveta, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3287-3287
Open Access | Times Cited: 16
Diagnostic Performance Evaluation of Multiparametric Magnetic Resonance Imaging in the Detection of Prostate Cancer with Supervised Machine Learning Methods
Hamide Nematollahi, Masoud Moslehi, Fahimeh Aminolroayaei, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 806-806
Open Access | Times Cited: 16
The effectiveness of chitosan as a hemostatic in dentistry in patients with antiplatelet/anticoagulant therapy: systematic review with meta-analysis
Giuseppe Minervini, Rocco Franco, Maria Maddalena Marrapodi, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
Naseruddin Höti, T. Mamie Lih, Mingming Dong, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 960-960
Open Access | Times Cited: 12
The value of a panel of circulating microRNAs in screening prostate cancer
Chen Sun, Chong Lu, Xinji Li, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 686-698
Open Access | Times Cited: 3
Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
Micael F. M. Gonçalves, Teresa Pina‐Vaz, Ângela Rita Fernandes, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1423-1423
Open Access | Times Cited: 9
A Novel Blood Proteomic Signature for Prostate Cancer
Ammara Muazzam, Matt Spick, Olivier Cexus, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1051-1051
Open Access | Times Cited: 8
Caveolin-1 scaffolding domain-derived peptide enhances erectile function by regulating oxidative stress, mitochondrial dysfunction, and apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury
Yuhang Xi, Zejia Feng, Tian Xia, et al.
Life Sciences (2024) Vol. 348, pp. 122694-122694
Closed Access | Times Cited: 2
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6094-6094
Open Access | Times Cited: 12
tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer
Weigang Liu, Mengqian Yu, Cheng Sheng, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 981-999
Open Access | Times Cited: 5
DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology
Ioanna Maria Grypari, Vassiliki Tzelepi, Kostis Gyftopoulos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11418-11418
Open Access | Times Cited: 5
Targeting GLI1 and BAX by nanonoscapine could impede prostate adenocarcinoma progression
Mohammad Hossein Derakhshan Nazari, Ronak Heidarian, Mina Masoudnia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis
Davide Vecchiotti, Letizia Clementi, Emanuele Cornacchia, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3215-3215
Open Access | Times Cited: 1
METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer
Jui‐Chuang Wu, Guang‐Jer Wu
Biomedicines (2023) Vol. 11, Iss. 1, pp. 205-205
Open Access | Times Cited: 4
Illustration of association between change in prostate-specific antigen (PSA) values and time to tumor status after treatment for prostate cancer patients: a joint modelling approach
Madiha Liaqat, Shahid Kamal, Florian Fischer
BMC Urology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
The Molecular Mechanism and Therapeutic Application of Autophagy for Urological Disease
Kuang-Shun Chueh, Jian‐He Lu, Tai-Jui Juan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14887-14887
Open Access | Times Cited: 3
Prognostic value of Controlling Nutritional Status score for postoperative complications and biochemical recurrence in prostate cancer patients undergoing laparoscopic radical prostatectomy
Tianyu Xiong, Xiaobo Ye, Guangyi Zhu, et al.
Current Urology (2023) Vol. 18, Iss. 1, pp. 43-48
Open Access | Times Cited: 3
Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules
Mohd Jameel, Homa Fatma, Людмила Надточий, et al.
Life (2023) Vol. 13, Iss. 10, pp. 1976-1976
Open Access | Times Cited: 2
miR-26a-5p restoration via EZH2 silencing blocks the IL-6/STAT3 axis to repress the growth of prostate cancer
Wenqiang Zhang, Qiwei Nie, Xuling Zhang, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 12, pp. 1285-1297
Closed Access | Times Cited: 2
Microbiome in Bladder Cancer: A Systematic Review
Yong Nam Gwon, Jae-Joon Park, Ki-Soo Lee, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 84-84
Open Access | Times Cited: 4
Assessing the genetic relationship between phimosis and 26 urogenital diseases: a Mendelian randomization study
Wei Li, Ying Yu, Hu Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top